These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients. Demir M; Göktürk S; Oztürk NA; Serin E; Yilmaz U Digestion; 2010; 82(1):47-53. PubMed ID: 20410684 [TBL] [Abstract][Full Text] [Related]
56. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043 [TBL] [Abstract][Full Text] [Related]
57. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068 [TBL] [Abstract][Full Text] [Related]
58. Treatment of Helicobacter pylori infection. Miehlke S; Bayerdörffer E; Graham DY Semin Gastrointest Dis; 2001 Jul; 12(3):167-79. PubMed ID: 11478749 [TBL] [Abstract][Full Text] [Related]